SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000905148-24-001481
Filing Date
2024-05-16
Accepted
2024-05-16 18:52:30
Documents
2
Period of Report
2024-05-13

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 6751
2 petersonpoa.htm EX-24 10721
  Complete submission text file 0000905148-24-001481.txt   18835
Mailing Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 617-207-8979
Acrivon Therapeutics, Inc. (Issuer) CIK: 0001781174 (see all company filings)

IRS No.: 825125532 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 480 ARSENAL WAY SUITE 100 WATERTOWN MA 02472
Business Address
Peterson Katharine (Reporting) CIK: 0002022214 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41551 | Film No.: 24957268